Modern Healthcare September 5, 2019
Merrill Goozner

Healthcare is dragging its feet on moving from fee-for-service to value-based medicine. Private equity firms buying up high-cost physician specialty practices will further hinder this much-needed evolution.

If policymakers want to expand value-based care—and Trump administration officials say they do—then they need to hit the pause button and take a closer look at the private equity buyout phenomenon. A trend once limited to dermatology, ophthalmology and dentistry is spreading rapidly among practices that are among the costliest in medicine, including orthopedics, gastroenterology and urology.

Anyone who doubts private equity takeovers can financially harm patients and subvert cost control should take a closer look at the balance-billing fiasco. Most of the “out of network” services that lead to large balance bills...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Mergers & Acquisitions / JV, Payment Models, Physician, Provider, Trends, Value Based
Ilant Health Raises Extended Seed Round of $5.5M for Obesity Management Platform
Podcast: The State of Antitrust & Private Equity in Health Care w/ Brent Fulton
Metsera lands with $290m to take on obesity giants
Private equity bankruptcies in healthcare explode 112% in 5 years
California’s AB 3129: A New Hurdle for Private Equity Health Care Transactions on the Horizon?

Share This Article